Discontinued — last reported Q2 '17

Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price

Medline, Inc. Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price remained flat by 0.0% to $11.97 in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ2 2015

Last reportedQ2 2017

How to read this metric

Reflects the valuation at which the company is currently incentivizing its employees for future performance.

Detailed definition

This is the average exercise price for stock options that are still in the vesting period. It provides insight into the...

Peer comparison

Useful for comparing the 'strike price' of recent equity grant cycles across the industry.

Metric ID: other_sharebased_compensation_arrangement_by_sharebased__e5aef0

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$11.97	$11.97
QoQ Change	—	+0.0%

Range$11.97 – $11.97

Frequently Asked Questions

What is Medline, Inc. 's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price?: Medline, Inc. (MDLN) reported share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price of $11.97 in Q1 2026.
What does share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price mean?: The average price employees will pay to exercise their stock options once they finish vesting.